Trials / Completed
CompletedNCT02296892
A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy
A Phase III Study Evaluating the Efficacy and Safety of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in Patients Undergoing Bronchoscopy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 446 (actual)
- Sponsor
- Paion UK Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, double-blind, randomized, placebo and active controlled, multi-center, parallel group study comparing remimazolam to placebo, with an additional open label arm for midazolam, in patients undergoing a bronchoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam | For induction and maintenance of sedation |
| DRUG | Placebo | Inactive control arm |
| DRUG | Midazolam | For induction and maintenance of sedation |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2017-03-01
- Completion
- 2017-03-13
- First posted
- 2014-11-21
- Last updated
- 2020-03-18
- Results posted
- 2019-03-12
Locations
14 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02296892. Inclusion in this directory is not an endorsement.